Abstract


Amaç: Çalışma, psödotümör serebri tanısı konulan olgularımızın klinik, laboratuvar bulgularını ve tedavilerini geriye dönük olarak gözden geçirmek ve 2013 yılında Friedman ve ark. tarafından yeniden belirlenen tanı ölçütlerine göre hastaları yeniden tanımlayarak literatür ile karşılaştırmak amacıyla planlanmıştır. 

Gereç ve Yöntemler: Çocuk Nöroloji Kliniği’nde 40 psödotümör serebri tanılı hastalar klinik bulguları ve tedavileri yönünden geriye dönük olarak incelendi. Tanılar Modifiye Dandy kriterleri ve 2013 Friedman tanı ölçütlerine göre tekrar karşılaştırıldı. 

Bulgular: Modifiye Dandy kriterlerine göre “kesin psödotümör serebri” tanısı alan 40 hastanın 2013 tanı kriterlerine göre tekrar sınıflandırıldığında 37’sinin tanısında değişiklik olmazken, üç hastanın “olası psödotümör serebri” grubuna kaydığı görüldü. Hastaların yaş ortalaması 11.15±3.32 yıl olup, %40’ı prepübertal, %60’ı pübertal dönemde idi. Yirmi sekiz hastaya (%70) birincil psödotümör serebri, 12 hastaya ise ikincil psödotümör serebri (%30) tanısı kondu. Baş ağrısı hastaların en sık başvuru şikayeti (%55)’di. Tüm hastaların medikal tedavi aldığı saptandı. Tedaviye yanıt vermeyen bir hastaya ise lumboperitoneal şant takıldığı tespit edildi. 

Sonuç: Hastalarımızın belirti ve bulgularının literatür ile uyumlu olduğu görüldü. Birincil psödotümör serebrili hastalarımızın %53.5’nin obezite ile ilişkili olduğu, ikincil psödotümör serebri nedenleri açısından ise nedenlerin literatür ile benzeştiği ve çoğunun medikal tedaviye yanıt verdiği gözlendi. Eski ve yeni tanı ölçütlerinin kullanılmasının tanı ve tedavi açısından farklılık yaratmayacağı saptandı. 

Keywords: Çocuk, 2013 Friedman kriterleri

References

  1. 1. Phillips PH, Sheldon CA. Pediatric pseudotumor cerebri syndrome.
  2. J Neuroophthalmol 2017;37:33–40.
  3. 2. Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the
  4. pseudotumor cerebri syndrome in adults and children. Neurology
  5. 2013;81:1159-65.
  6. 3. Spennato P, Ruggiero C, Parlato RS, et al. Pseudotumor cerebri.
  7. Childs Nerv Syst 2011;27:215–35.
  8. 4. Tibussek D, Schneider DT, Vandemeulebroecke N, Turowski
  9. B, Messing-Juenger M, Willems PH, et al. Clinical spectrum of
  10. the pseudotumor cerebri complex in children. Childs Nerv Syst
  11. 2010;26:313-21.
  12. 5. Wraige E, Chandler C, Pohl KR. Idiopathic intracranial hypertension:
  13. Is papil edema inevitable? Arch Dis Child 2002;87:223-4.
  14. 6. Per H, Canpolat M, Gümüş H, Poyrazoğlu HG, Yıkılmaz A,
  15. Karaküçük S, et al. Clinical spectrum of the pseudotumor cerebri
  16. in children: Etiological, clinical features, treatment and prognosis.
  17. Brain Dev 2013;35:561-8.
  18. 7. Incecik F, Hergüner MO, Altunbaşak S. Evaluation of sixteen
  19. children with pseudotumor cerebri. Turk J Pediatr 2011;53:55-8.
  20. 8. Değerliyurt A, Teber S, Karakaya G, Güven A, Şeker ED, Arhan
  21. EP, et al. Pseudotumor cerebri/idiopathic intracranial hypertension
  22. in children: An experience of a tertiary care hospital. Brain Dev
  23. 2014;36:690-9.
  24. 9. Hacifazlioglu N, Yilmaz Y. Pseudotumour cerebri in children:
  25. Etiological, clinical features and treatment modalities. Eur J Paediatr
  26. Neurol 2012;16:349-55.
  27. 10. Fuqua JS. Treatment and outcomes of precocious puberty: An
  28. update. Clin Endocrinol Metab 2013;98:2198-207.
  29. 11. Masri A, Jaafar A, Noman R, Gharaibeh A, Ababneh OH. Intracranial
  30. hypertension in children: Etiologies, clinical features, and outcome.
  31. J Child Neurol 2015;30:1562-8.
  32. 12. Avery RA, Shah SS, Licht DJ, et al. Reference range for
  33. cerebrospinal fluid opening pressure in children. N Engl J Med
  34. 2010;363:891-3.
  35. 13. Smith JL. Whence pseudotumor cerebri?. J Clin Neuroophthalmol
  36. 1985;5:55-6.
  37. 14. Cleves-Bayon C. Idiopathic Intracranial Hypertension in Children
  38. and Adolescents: An Update. Headache 2018;58:485-93.
  39. 15. Tibussek D, Distelmaier F, Karenfort M, Harmsen S, Klee D,
  40. Mayatepek E. Probable pseudotumor cerebri complex in 25
  41. children. Further support of a concept. Eur J Paediatr Neurol
  42. 2017;21:280-5.
  43. 16. Inger HE, Rogers DL, McGregor ML, Aylward SC, Reem RE.
  44. Diagnostic criteria in pediatric intracranial hypertension. J AAPOS
  45. 2017;21:492-5.
  46. 17. Maralani PJ, Hassanlou M, Torres C, et al. Accuracy of brain
  47. imaging in the diagnosis of idiopathic intracranial hypertension. Clin
  48. Radiol 2012;67:656-63.
  49. 18. Gorkem SB, Doganay S, Canpolat M, et al. MR imaging findings
  50. in children with pseudotumor cerebri and comparison with healthy
  51. controls. Childs Nerv Syst 2015;31:373-80.
  52. 19. Tibussek D, Schneider DT, Vandemeulebroecke N, et al. Clinical
  53. spectrum of the pseudotumor cerebri complex in children. Childs
  54. Nerv Syst 2010;26:313-21.
  55. 20. Kesler A, Fattal-Valevski A. Idiopathic intracranial hypertension in
  56. the pediatric population. J Child Neurol 2002;17:745-8.
  57. 21. Couch R, Camfield PR, Tibbles JA. The changing picture of
  58. pseudotumor cerebri in children. Can J Neurol Sci 1985;12:48-50.
  59. 22. Standridge SM. Idiopathic intracranial hypertension in children: A
  60. review and algorithm. Pediatr Neurol 2010;43:377-90.
  61. 23. Matthews YY, Dean F, Lim MJ, et al. Pseudotumor cerebri
  62. Syndrome in childhood: Incidence, clinical profile and risk factors
  63. in a national prospective population-based cohort study. Arch Dis
  64. Child 2017;102:715-21.
  65. 24. Sinclair AJ, Walker EA, Burdon MA, et al. Cerebrospinal fluid
  66. corticosteroid levels and cortisol metabolism in patients with
  67. idiopathic intracranial hypertension: A link between 11beta-HSD1
  68. and intracranial pressure regulation? J Clin Endocrinol Metab
  69. 2010;95:5348-56.
  70. 25. Sinclair AJ, Onyimba CU, Khosla P, et al. Corticosteroids, 11betahydroxysteroid
  71. dehydrogenase isozymes and the rabbit choroid
  72. plexus. J Neuroendocrinol 2007;19:614-20.
  73. 26. Salpietro V, Polizzi A, Berte LF, et al: Idiopathic intracranial
  74. hypertension: A unifying neuroendocrine hypothesis through the
  75. adrenal- brain axis. Neuro Endocrinol Lett 2012;33:569–73.
  76. 27. Randhawa S, Van Stavern GP. Idiopathic intracranial hypertension
  77. (pseudotumor cerebri). Curr Opin Ophthalmol 2008;19:445-53.
  78. 28. Distelmaier F, Tibussek D, Schneider DT, Mayatepek E. Seasonal
  79. variation and atypical presentation of idiopathic intracranial
  80. hypertension in prepubertal children. Cephalalgia 2007;27:1261-4.
  81. 29. Keren T, Lahat E. Pseudotumor cerebri as a presenting symptom
  82. of acute sinusitis in a child. Pediatr Neurol 1998;19:153-4.
  83. 30. Lin A, Foroozan R, Danesh-Mayer HV, De Salvo G, Savino PJ,
  84. Sergott RC. Occurence of cerebral venous sinus thrombosis
  85. in patients with presumed idiopathic intracranial hypertension.
  86. Ophthalmology 2006;113:2281-4.
  87. 31. Standridge SM, O’Brien SH. Idiopathic intracranial hypertension in
  88. a pediatric population: A retrospective analysis of the initial imaging
  89. evaluation. J Child Neurol 2008;23:1308-11.
  90. 32. Paley GL, Sheldon CA, Burrows EK, Chilutti MR, Liu GT, Mc
  91. Cormack SE. Overweight and obesity in pediatric secondary
  92. pseudotumor cerebri syndrome. Am J Ophthalmol 2015;159:344-
  93. 52.
  94. 33. Benzimra JD, Simon S, Sinclair AJ, Mollan SP. Sight-threatening
  95. pseudotumour cerebri associated with excess vitamin A
  96. supplementation. Pract Neurol 2015;15:72-3.
  97. 34. Raeeskarami SR, Shahbaznejad L, Assari R, Aghighi Y.
  98. Pseudotumor cerebri as the first manifestation of juvenile systemic
  99. lupus erythematosus. Iran J Pediatr 2016;26:5176.
  100. 35. Kim JM, Kwok SK, Ju JH, Kim HY, Park SH. Idiopathic intracranial
  101. hypertension as a significant cause of intractable headache in
  102. patients with systemic lupus erythematosus: A 15-year experience.
  103. Lupus 2012;21:542–7.
  104. 36. Henry M, Driscoll MC, Miller M, Chang T, Minniti CP. Pseudotumor
  105. cerebri in children with sickle cell disease: A case series. Pediatrics
  106. 2004;113:265-9.
  107. 37. Tugal O, Jacobson R, Berezin S, et al. Recurrent benign intracranial
  108. hypertension due to iron deficiency anemia. Case report and review
  109. of the literature. Am J Pediatr Hematol Oncol 1994;16:266– 70.
  110. 38. Lessel S: Pediatric pseudotumor cerebri (idiopathic intracranial
  111. hypertension). Surv Ophthalmol 1992;37:155–66.
  112. 39. Wall M, Kupersmith MJ, Kieburtz KD, et al. The idiopathic
  113. intracranial hypertension treatment trial: Clinical profile at baseline.
  114. JAMA Neurol 2014;71:1327-8.40. Wall M, George D. Idiopathic intracranial hypertension. A
  115. prospective study of 50 patients. Brain 1991;114:155.
  116. 41. Corbett JJ, Savino PJ, Thompson HS, et al. Visual loss in
  117. pseudotumor cerebri. Follow-up of 57 patients from five to 41
  118. years and a profile of 14 patients with permanent severe visual
  119. loss. Arch Neurol 1982;39:461-74.
  120. 42. Lessell S, Rosman NP: Permanent visual impairment in childhood
  121. pseudotumor cerebri. Arch Neurol 1986;43:801–4.
  122. 43. Miller NR, Newman NJ: Papilledema. In: Walsh F, Hoyt B (eds).
  123. Clinical Neuroophthalmology. 5th ed. Baltimore: Williams & Wilkins,
  124. 1998:478–548.
  125. 44. Friedman DI: Pseudotumor cerebri. Neurosurg Clin North Am
  126. 1999;10:609–21.
  127. 45. Babikian P, Corbett J, Bell W. Idiopathic intracranial hypertension in
  128. children:The Iowa experience. J Child Neurol 1994;9:144–9.
  129. 46. Tovia E, Reif S, Oren A, Mitelpunkt A, Fattal-Valevski A. Treatment
  130. response in pediatric patients with pseudotumor cerebri syndrome.
  131. J Neuroophthalmol 2017;37:393-7.
  132. 47. Aylward SC, Way AL. Pediatric intracranial hypertension: A current
  133. literature review. Curr Pain Headache Rep 2018;22:14.
  134. 48. Celebisoy N, Gökçay F, Sirin H, Akyürekli O. Treatment of idiopathic
  135. intracranial hypertension: Topiramate vs acetazolamide, an openlabel
  136. study. Acta Neurol Scand 2007;116:322-7.
  137. 49. Orssaud C, Dureau P, Zerah M, et al. Benign childhood intracranial
  138. hypertension. J Fr Ophtalmol 2001;24:54-9.
  139. 50. Altan-Yaycioglu R, Canan H, Saygi S. Intravitreal ranibizumab
  140. injection in peripapillary CNVM related to idiopathic intracranial
  141. hypertension. J Pediatr Ophthalmol Strabismus 2017;54:27-30.
  142. 51. Phillips PH, Sheldon CA. Pediatric pseudotumor cerebri syndrome.
  143. J Neuroophthalmol 2017;37:33-40.

Copyright and license

How to cite

1.
Özkale Y. Psödotümör Serebri; Tek Merkez Deneyimi. Turk J Pediatr Dis [Internet]. 2019 May 24 [cited 2025 May 24];13(3):193-202. Available from: https://turkjpediatrdis.org/article/view/612